Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.07) per share. This is a 69.57 percent increase over losses of $(0.23) per share from the same period last year.
NRx Pharma Chair, CEO To Present Co. Business Update At HC Wainwright BioConnect Conference Jan. 10, 2022 At 7 a.m. EST
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, today announced its Chairman of the Board and Chief Executive Officer, Prof Jonathan Javitt, MD, MPH, will be presenting
